First Time Loading...

Harpoon Therapeutics Inc
NASDAQ:HARP

Watchlist Manager
Harpoon Therapeutics Inc Logo
Harpoon Therapeutics Inc
NASDAQ:HARP
Watchlist
Price: 23.01 USD Market Closed
Updated: May 3, 2024

Harpoon Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Harpoon Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Harpoon Therapeutics Inc
NASDAQ:HARP
Cash from Investing Activities
$89.7m
CAGR 3-Years
N/A
CAGR 5-Years
82%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
-76%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$26.2B
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$3.2B
CAGR 3-Years
-256%
CAGR 5-Years
-17%
CAGR 10-Years
-25%

See Also

What is Harpoon Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
89.7m USD

Based on the financial report for Dec 31, 2022, Harpoon Therapeutics Inc's Cash from Investing Activities amounts to 89.7m USD.

What is Harpoon Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
82%

Over the last year, the Cash from Investing Activities growth was 161%.